Physiology of freezing of gait

Annals of Neurology

Volumn 80, Issue 5, 2016, Pages 644-659

  Snijders, Anke H ^a,b   Takakusaki, Kaoru ^c   Debu, Bettina ^d   Lozano, Andres M ^e   Krishna, Vibhor ^e,f   Fasano, Alfonso ^g   Aziz, Tipu Z ^h   Papa, Stella M ⁱ   Factor, Stewart A ⁱ   Hallett, Mark ^j  

^a RADBOUD UNIVERSITY   (Netherlands)

^b Maas Hospital Pantein   (Netherlands)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITY OF TORONTO   (Canada)

^f OHIO STATE UNIVERSITY   (United States)

^g TORONTO WESTERN HOSPITAL   (Canada)

^h JOHN RADCLIFFE HOSPITAL   (United Kingdom)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CORPUS STRIATUM; FREEZING OF GAIT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GAIT DISORDER; HUMAN; MESENCEPHALON; NEUROPHYSIOLOGY; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIMATE; PRIORITY JOURNAL; REVIEW; SUPPLEMENTARY MOTOR AREA; THEORETICAL STUDY; WALKING; ANIMAL; BRAIN DEPTH STIMULATION; GAIT DISORDERS, NEUROLOGIC; PATHOPHYSIOLOGY;

ANIMALS; DEEP BRAIN STIMULATION; FUNCTIONAL NEUROIMAGING; GAIT DISORDERS, NEUROLOGIC; HUMANS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS;

EID: 84991260808     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24778     Document Type: Review

References (125)

1. Giladi N. Freezing of gait. Clinical overview. Adv Neurol 2001;87:191–197.
2. Walton CC, Shine JM, Hall JM, et al. The major impact of freezing of gait on quality of life in Parkinson's disease. J Neurol 2015;262:108–115.
3. Giladi N, Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 2008;23(suppl 2):S423–S425.
4. Schaafsma JD, Balash Y, Gurevich T, et al. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 2003;10:391–398.
5. Espay AJ, Fasano A, van Nuenen BF, et al. “On” state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology 2012;78:454–457.
6. Snijders AH, van de Warrenburg BP, Giladi N, Bloem BR. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007;6:63–74.
7. Woollacott M, Shumway-Cook A. Attention and the control of posture and gait: a review of an emerging area of research. Gait Posture 2002;16:1–14.
8. Morton SM, Bastian AJ. Cerebellar control of balance and locomotion. Neuroscientist 2004;10:247–259.
9. Hinsey JC, Ranson SW, McNattin FR. The role of the hypothalamus and mesencephalon in locomotion. Arch Neurol Psychiatry 1930:1–43.
10. Mori S. Integration of posture and locomotion in acute decerebrate cats and in awake, freely moving cats. Prog Neurobiol 1987;28:161–195.
11. Shik ML, Orlovsky GN. Neurophysiology of locomotor automatism. Physiol Rev 1976;56:465–501.
12. Brooks VB, Stoney SD Jr. Motor mechanisms: the role of the pyramidal system in motor control. Annu Rev Physiol 1971;33:337–392.
13. Yakovenko S, Drew T. A motor cortical contribution to the anticipatory postural adjustments that precede reaching in the cat. J Neurophysiol 2009;102:853–874.
14. Marigold DS, Drew T. Contribution of cells in the posterior parietal cortex to the planning of visually guided locomotion in the cat: effects of temporary visual interruption. J Neurophysiol 2011;105:2457–2470.
15. Nakajima K, Mori F, Tachibana A, et al. Cortical mechanisms for the control of bipedal locomotion in Japanese monkeys: I. Local inactivation of the primary motor cortex (M1). Neurosci Res 2003;46(suppl 1):S156.
16. Mori F, Nakajima K, Tachibana A. Cortical mechanisms for the control of bipedal locomotion in Japanese monkeys: II. Local inactivation of the supplementary motor area (SMA). Neurosci Res 2003;46(suppl 1):S157.
17. Keizer K, Kuypers HG. Distribution of corticospinal neurons with collaterals to the lower brain stem reticular formation in monkey (Macaca fascicularis). Exp Brain Res 1989;74:311–318.
18. Matsuyama K, Drew T. Organization of the projections from the pericruciate cortex to the pontomedullary brainstem of the cat: a study using the anterograde tracer Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 1997;389:617–641.
19. Aravamuthan BR, McNab JA, Miller KL, et al. Cortical and subcortical connections within the pedunculopontine nucleus of the primate Macaca mulatta determined using probabilistic diffusion tractography. J Clin Neurosci 2009;16:413–420.
20. Mori S, Matsui T, Kuze B, et al. Stimulation of a restricted region in the midline cerebellar white matter evokes coordinated quadrupedal locomotion in the decerebrate cat. J Neurophysiol 1999;82:290–300.
21. Grillner S, Georgopoulos AP, Jordan LM. Selection and initiation of motor behavior. In: Stein PSG, ed. Neurons, networks, and motor behavior. Cambridge, MA: MIT Press, 1997:3–19.
22. Sherman D, Fuller PM, Marcus J, et al. Anatomical location of the mesencephalic locomotor region and its possible role in locomotion, posture, cataplexy, and parkinsonism. Front Neurol 2015;6:140.
23. Alam M, Schwabe K, Krauss JK. The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation. Brain 2011;134(pt 1):11–23.
24. Takakusaki K, Chiba R, Nozu T, Okumura T. Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems. J Neural Transm (Vienna) 2016;123:695–729.
25. Petzold A, Valencia M, Pal B, Mena-Segovia J. Decoding brain state transitions in the pedunculopontine nucleus: cooperative phasic and tonic mechanisms. Front Neural Circuits 2015;9:68.
26. Takakusaki K, Habaguchi T, Ohtinata-Sugimoto J, et al. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 2003;119:293–308.
27. Takakusaki K, Habaguchi T, Saitoh K, Kohyama J. Changes in the excitability of hindlimb motoneurons during muscular atonia induced by stimulating the pedunculopontine tegmental nucleus in cats. Neuroscience 2004;124:467–480.
28. Takakusaki K, Oohinata-Sugimoto J, Saitoh K, Habaguchi T. Role of basal ganglia-brainstem systems in the control of postural muscle tone and locomotion. Prog Brain Res 2004;143:231–237.
29. Takakusaki K, Takahashi K, Saitoh K, et al. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol 2005;568(pt 3):1003–1020.
30. Takakusaki K, Obara K, Nozu T, Okumura T. Modulatory effects of the GABAergic basal ganglia neurons on the PPN and the muscle tone inhibitory system in cats. Arch Ital Biol 2011;149:385–405.
31. Armstrong DM. Supraspinal contributions to the initiation and control of locomotion in the cat. Prog Neurobiol 1986;26:273–361.
32. Garcia-Rill E, Houser CR, Skinner RD, et al. Locomotion-inducing sites in the vicinity of the pedunculopontine nucleus. Brain Res Bull 1987;18:731–738.
33. Mori S, Matsui T, Kuze B, et al. Cerebellar-induced locomotion: reticulospinal control of spinal rhythm generating mechanism in cats. Ann N Y Acad Sci 1998;860:94–105.
34. Fung SJ, Barnes CD. Evidence of facilitatory coerulospinal action in lumbar motoneurons of cats. Brain Res 1981;216:299–311.
35. Mori S, Kawahara K, Sakamoto T, et al. Setting and resetting of level of postural muscle tone in decerebrate cat by stimulation of brain stem. J Neurophysiol 1982;48:737–748.
36. Sakai M, Matsunaga M, Kubota A, et al. Reduction in excessive muscle tone by selective depletion of serotonin in intercollicularly decerebrated rats. Brain Res 2000;860:104–111.
37. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007;64:20–24.
38. Takakusaki K, Tomita N, Yano M. Substrates for normal gait and pathophysiology of gait disturbances with respect to the basal ganglia dysfunction. J Neurol 2008;255(suppl 4):19–29.
39. Slawinska U, Kasicki S. Theta-like rhythm in depth EEG activity of hypothalamic areas during spontaneous or electrically induced locomotion in the rat. Brain Res 1995;678:117–126.
40. Swanson LW, Mogenson GJ. Neural mechanisms for the functional coupling of autonomic, endocrine and somatomotor responses in adaptive behavior. Brain Res 1981;228:1–34.
41. Lynd-Balta E, Haber SN. Primate striatonigral projections: a comparison of the sensorimotor-related striatum and the ventral striatum. J Comp Neurol 1994;345:562–578.
42. Stephenson-Jones M, Ericsson J, Robertson B, Grillner S. Evolution of the basal ganglia: dual-output pathways conserved throughout vertebrate phylogeny. J Comp Neurol 2012;520:2957–2973.
43. Matsumura M, Nambu A, Yamaji Y, et al. Organization of somatic motor inputs from the frontal lobe to the pedunculopontine tegmental nucleus in the macaque monkey. Neuroscience 2000;98:97–110.
44. Jacobs JV, Lou JS, Kraakevik JA, Horak FB. The supplementary motor area contributes to the timing of the anticipatory postural adjustment during step initiation in participants with and without Parkinson's disease. Neuroscience 2009;164:877–885.
45. Marsden CD. Primate models of neurological disorders. Introduction. Adv Neurol 1975;10:3–4.
46. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979–980.
47. Langston JW, Forno LS, Tetrud J, et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 1999;46:598–605.
48. Burns RS, Chiueh CC, Markey SP, et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1983;80:4546–4550.
49. Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985;35:949–956.
50. Revuelta GJ, Uthayathas S, Wahlquist AE, et al. Non-human primate FOG develops with advanced parkinsonism induced by MPTP treatment. Exp Neurol 2012;237:464–469.
51. Moore ST, MacDougall HG, Ondo WG. Ambulatory monitoring of freezing of gait in Parkinson's disease. J Neurosci Methods 2008;167:340–348.
52. Forno LS, Langston JW, DeLanney LE, et al. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 1986;20:449–455.
53. Karachi C, Grabli D, Bernard FA, et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 2010;120:2745–2754.
54. Grabli D, Karachi C, Folgoas E, et al. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems. J Neurosci 2013;33:11986–11993.
55. Kucinski A, Paolone G, Bradshaw M, et al. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. J Neurosci 2013;33:16522–16539.
56. Kucinski A, Albin RL, Lustig C, Sarter M. Modeling falls in Parkinson's disease: slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behav Brain Res 2015;282:155–164.
57. Gut NK, Winn P. Deep brain stimulation of different pedunculopontine targets in a novel rodent model of parkinsonism. J Neurosci 2015;35:4792–4803.
58. Roseberry TK, Lee AM, Lalive AL, et al. Cell-type-specific control of brainstem locomotor circuits by basal ganglia. Cell 2016;164:526–537.
59. Bouvier J, Caggiano V, Leiras R, et al. Descending command neurons in the brainstem that halt locomotion. Cell 2015;163:1191–1203.
60. Hasselmo ME, Sarter M. Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 2011;36:52–73.
61. Semba K, Fibiger HC. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J Comp Neurol 1992;323:387–410.
62. Bohnen NI, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003;60:1745–1748.
63. Bohnen NI, Muller ML, Kotagal V, et al. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. J Cereb Blood Flow Metab 2012;32:1609–1617.
64. Muller ML, Bohnen NI. Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep 2013;13:377.
65. Snijders AH, Leunissen I, Bakker M, et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 2011;134:59–72.
66. Peterson DS, Pickett KA, Duncan R, et al. Gait-related brain activity in people with Parkinson disease with freezing of gait. PLoS One 2014;9:e90634.
67. Vercruysse S, Spildooren J, Heremans E, et al. The neural correlates of upper limb motor blocks in Parkinson's disease and their relation to freezing of gait. Cereb Cortex 2014;24:3154–3166.
68. Nieuwboer A, Vercruysse S, Feys P, et al. Upper limb movement interruptions are correlated to freezing of gait in Parkinson's disease. Eur J Neurosci 2009;29:1422–1430.
69. Vercruysse S, Gilat M, Shine JM, et al. Freezing beyond gait in Parkinson's disease: a review of current neurobehavioral evidence. Neurosci Biobehav Rev 2014;43:213–227.
70. Shine JM, Matar E, Ward PB, et al. Differential neural activation patterns in patients with Parkinson's disease and freezing of gait in response to concurrent cognitive and motor load. PLoS One 2013;8:e52602.
71. Shine JM, Matar E, Ward PB, et al. Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease. Brain 2013;136(pt 4):1204–1215.
72. Hagen YJ, Snijders AH, Munneke M, et al. Rapid axial turns: the best way to provoke freezing of gait in Parkinson's disease. Parkinsonism Relat Disord 2008;14:S26.
73. Fling BW, Cohen RG, Mancini M, et al. Functional reorganization of the locomotor network in Parkinson patients with freezing of gait. PLoS One 2014;9:e100291.
74. Androulidakis AG, Mazzone P, Litvak V, et al. Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Exp Neurol 2008;211:59–66.
75. Weinberger M, Hamani C, Hutchison WD, et al. Pedunculopontine nucleus microelectrode recordings in movement disorder patients. Exp Brain Res 2008;188:165–174.
76. Thevathasan W, Pogosyan A, Hyam JA, et al. Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism. Brain 2012;135(pt 1):148–160.
77. Tsang EW, Hamani C, Moro E, et al. Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology 2010;75:950–959.
78. Fraix V, Bastin J, David O, et al. Pedunculopontine nucleus area oscillations during stance, stepping and freezing in Parkinson's disease. PLoS One 2013;8:e83919.
79. Tattersall TL, Stratton PG, Coyne TJ, et al. Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Nat Neurosci 2014;17:449–454.
80. Lau B, Welter ML, Belaid H, et al. The integrative role of the pedunculopontine nucleus in human gait. Brain 2015;138(pt 5):1284–1296.
81. Jenkinson N, Nandi D, Muthusamy K, et al. Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus. Mov Disord 2009;24:319–328.
82. Zweig RM, Whitehouse PJ, Casanova MF, et al. Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann Neurol 1987;22:18–25.
83. Zweig RM, Jankel WR, Hedreen JC, et al. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989;26:41–46.
84. Aziz TZ, Davies L, Stein J, France S. The role of descending basal ganglia connections to the brain stem in parkinsonian akinesia. Br J Neurosurg 1998;12:245–249.
85. Munro-Davies LE, Winter J, Aziz TZ, Stein JF. The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia. Exp Brain Res 1999;129:511–517.
86. Pereira EA, Nandi D, Jenkinson N, et al. Pedunculopontine stimulation from primate to patient. J Neural Transm 2011;118:1453–1460.
87. Nandi D, Liu X, Winter JL, et al. Deep brain stimulation of the pedunculopontine region in the normal non-human primate. J Clin Neurosci 2002;9:170–174.
88. Nandi D, Aziz TZ, Giladi N, et al. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain 2002;125(pt 11):2418–2430.
89. Jenkinson N, Nandi D, Aziz TZ, Stein JF. Pedunculopontine nucleus: a new target for deep brain stimulation for akinesia. Neuroreport 2005;16:1875–1876.
90. Jenkinson N, Nandi D, Miall RC, et al. Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport 2004;15:2621–2624.
91. Jenkinson N, Nandi D, Oram R, et al. Pedunculopontine nucleus electric stimulation alleviates akinesia independently of dopaminergic mechanisms. Neuroreport 2006;17:639–641.
92. Mazzone P, Sposato S, Insola A, Scarnati E. The deep brain stimulation of the pedunculopontine tegmental nucleus: towards a new stereotactic neurosurgery. J Neural Transm (Vienna) 2011;118:1431–1451.
93. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130(pt 6):1596–1607.
94. Ferraye MU, Debu B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133(pt 1):205–214.
95. Moro E, Hamani C, Poon YY, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010;133(pt 1):215–224.
96. Nosko D, Ferraye MU, Fraix V, et al. Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2015;86:674–679.
97. Khan S, Javed S, Mooney L, et al. Clinical outcomes from bilateral versus unilateral stimulation of the pedunculopontine nucleus with and without concomitant caudal zona incerta region stimulation in Parkinson's disease. Br J Neurosurg 2012;26:722–725.
98. Khan S, Mooney L, Plaha P, et al. Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease. Br J Neurosurg 2011;25:273–280.
99. Schrader C, Seehaus F, Capelle HH, et al. Effects of pedunculopontine area and pallidal DBS on gait ignition in Parkinson's disease. Brain Stimul 2013;6:856–859.
100. Lam S, Moro E, Poon YY, et al. Does dominant pedunculopontine nucleus exist? Brain 2015;138(pt 2):e323.
101. Thevathasan W, Cole MH, Graepel CL, et al. A spatiotemporal analysis of gait freezing and the impact of pedunculopontine nucleus stimulation. Brain 2012;135(pt 5):1446–1454.
102. Shih LC, Vanderhorst VG, Lozano AM, et al. Improvement of Pisa syndrome with contralateral pedunculopontine stimulation. Mov Disord 2013;28:555–556.
103. Ricciardi L, Piano C, Bentivoglio AR, Fasano A. Long-term effects of pedunculopontine nucleus stimulation for Pisa syndrome. Parkinsonism Relat Disord 2014;20:1445–1446.
104. Hazrati LN, Wong JC, Hamani C, et al. Clinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation. Mov Disord 2012;27:1304–1307.
105. Thevathasan W, Silburn PA, Brooker H, et al. The impact of low-frequency stimulation of the pedunculopontine nucleus region on reaction time in parkinsonism. J Neurol Neurosurg Psychiatry 2010;81:1099–1104.
106. Fischer J, Schwiecker K, Bittner V, et al. Modulation of attentional processing by deep brain stimulation of the pedunculopontine nucleus region in patients with parkinsonian disorders. Neuropsychology 2015;29:632–637.
107. Ballanger B, Lozano AM, Moro E, et al. Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H(2)O PET study. Hum Brain Mapp 2009;30:3901–3909.
108. Weiss PH, Herzog J, Potter-Nerger M, et al. Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers. Mov Disord 2015;30:1121–1125.
109. Yelnik J. PPN or PPD, what is the target for deep brain stimulation in Parkinson's disease? Brain 2007;130(pt 9):e79; author reply e80.
110. Zrinzo L, Zrinzo L, Hariz M. The peripeduncular nucleus: a novel target for deep brain stimulation? Neuroreport 2007;18:1631–1632; author reply 2–3.
111. Zrinzo L, Zrinzo LV, Tisch S, et al. Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain 2008;131(pt 6):1588–1598.
112. Mazzone P, Lozano A, Stanzione P, et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005;16:1877–1881.
113. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 1987;84:5976–5980.
114. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988;51:540–543.
115. Jellinger KA. Post mortem studies in Parkinson's disease—is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999;56:1–29.
116. Caliandro P, Insola A, Scarnati E, et al. Effects of unilateral pedunculopontine stimulation on electromyographic activation patterns during gait in individual patients with Parkinson's disease. J Neural Transm 2011;118:1477–1486.
117. Ostrem JL, Christine CW, Glass GA, et al. Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder. Stereotact Funct Neurosurg 2010;88:51–55.
118. Peppe A, Pierantozzi M, Chiavalon C, et al. Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease. Gait Posture 2010;32:512–518.
119. Davis JT, Lyons KE, Pahwa R. Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease. Clin Neurol Neurosurg 2006;108:461–464.
120. Nonnekes J, Snijders AH, Nutt JG, et al. Freezing of gait: a practical approach to management. Lancet Neurol 2015;14:768–778.
121. Cools R, D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 2011;69:e113–e125.
122. Vercruysse S, Vandenberghe W, Munks L, et al. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study. J Neurol Neurosurg Psychiatry 2014;85:871–877.
123. Mesulam MM, Geula C, Bothwell MA, Hersh LB. Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol 1989;283:611–633.
124. Thevathasan W, Coyne TJ, Hyam JA, et al. Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery 2011;69:1248–1253.
125. Mazzone P, Paoloni M, Mangone M, et al. Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson's disease: effects on gait initiation and performance. Gait Posture 2014;40:357–362.